Genetic factors in the metabolism of haloperidol.
Llerena
A
A
Dpt. of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
Dahl
M L
ML
Ekqvist
B
B
Bertilsson
L
L
D003647:Debrisoquin; D006207:Half-Life; D006220:Haloperidol / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D006801:Humans; D006900:Hydroxylation; D010641:Phenotype
C040692:4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol; D006220:Haloperidol; D003647:Debrisoquin